Abstract
The combined activity of MGBG (metylglyoxal-bis(guanylhydrazone)) with either cisplatin or carboplatin was investigated, towards the human breast cancer cell line MCF-7. While a dose- and time-dependent cytotoxic activity was already observed for MGBG alone, a synergistic and non-reversible effect was verified upon co-administration with these Pt-based drugs. Furthermore, toxicity against non-neoplastic cells was shown to be quite low for these drug cocktails, as opposed to either Pt-agents alone. These results may hopefully allow to use lower dosages of both MGBG and the Ptdrugs, minimising the drugs deleterious side effects while keeping antitumour efficacy, in an anticancer strategy that couples interference with polyamine homeostasis with DNA damage.
Keywords: Anticancer, Breast cancer, Carboplatin, Cisplatin, MGBG, Chemotherapy, MCF-7, Pt-based drugs, homeostasis, myelosuppression, mucositis, antitumour, difluormethylornithine, aromatase inhibitors
Letters in Drug Design & Discovery
Title: MGBG in Combined Anticancer Chemotherapy
Volume: 8 Issue: 10
Author(s): R. F. Goncalves, G. Kriechammer and M. P.M. Marques
Affiliation:
Keywords: Anticancer, Breast cancer, Carboplatin, Cisplatin, MGBG, Chemotherapy, MCF-7, Pt-based drugs, homeostasis, myelosuppression, mucositis, antitumour, difluormethylornithine, aromatase inhibitors
Abstract: The combined activity of MGBG (metylglyoxal-bis(guanylhydrazone)) with either cisplatin or carboplatin was investigated, towards the human breast cancer cell line MCF-7. While a dose- and time-dependent cytotoxic activity was already observed for MGBG alone, a synergistic and non-reversible effect was verified upon co-administration with these Pt-based drugs. Furthermore, toxicity against non-neoplastic cells was shown to be quite low for these drug cocktails, as opposed to either Pt-agents alone. These results may hopefully allow to use lower dosages of both MGBG and the Ptdrugs, minimising the drugs deleterious side effects while keeping antitumour efficacy, in an anticancer strategy that couples interference with polyamine homeostasis with DNA damage.
Export Options
About this article
Cite this article as:
F. Goncalves R., Kriechammer G. and P.M. Marques M., MGBG in Combined Anticancer Chemotherapy, Letters in Drug Design & Discovery 2011; 8 (10) . https://dx.doi.org/10.2174/157018011797655197
DOI https://dx.doi.org/10.2174/157018011797655197 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Targeting ADAM12 in Human Disease: Head, Body or Tail?
Current Pharmaceutical Design Concanavalin A, from an Old Protein to Novel Candidate Anti-Neoplastic Drug
Current Molecular Pharmacology Cyclopeptides from Marine Organisms
Mini-Reviews in Organic Chemistry Targeted Therapy for Advanced Prostate Cancer: Inhibition of the PI3K/Akt/mTOR Pathway
Current Cancer Drug Targets Verification between Original and Biosimilar Therapeutic Antibody Infliximab Using nSMOL Coupled LC-MS Bioanalysis in Human Serum
Current Pharmaceutical Biotechnology Ruthenium(II) Complexes as Potential Apoptosis Inducers in Chemotherapy
Anti-Cancer Agents in Medicinal Chemistry New Benzothiazole/thiazole-Containing Hydroxamic Acids as Potent Histone Deacetylase Inhibitors and Antitumor Agents
Medicinal Chemistry Outcome Measures Following Sonodynamic Photodynamic Therapy – A Case Series
Current Drug Therapy Melatonin Regulates Angiogenic Factors under Hypoxia in Breast Cancer Cell Lines
Anti-Cancer Agents in Medicinal Chemistry Sirtuin Modulators: Mechanisms and Potential Clinical Implications
Current Medicinal Chemistry Genetic Predisposition to Parkinson’s Disease and Cancer
Current Cancer Drug Targets Design and Virtual Screening Towards Synthesis of Novel Substituted Thiosemicarbozones as Ribonuleotide Reductase (RNR) Inhibitors with Improved Cellular Trafficking and Anticancer Activity
Current Topics in Medicinal Chemistry Tumor Thermal Ablation Enhancement by Micromaterials
Current Drug Delivery Cancer Stem-Cells Patents in the Context of their Therapeutic Purposes: Exploring the Latest Trends (2011-2015)
Recent Patents on Regenerative Medicine N6-methyladenine RNA Modification (m<sup>6</sup>A): An Emerging Regulator of Metabolic Diseases
Current Drug Targets Raman, Infrared and NMR Spectroscopy: Advances in Structural, Conformational and Environmental Analysis
Combinatorial Chemistry & High Throughput Screening Topics of Physiological and Pathophysiological Functions of Lymphatics
Current Molecular Medicine RAGE Signaling in Cell Adhesion and Inflammation
Current Pediatric Reviews Editorial:Tubulin-targeted Cancer Chemotherapeutics: Advances and Challenges
Current Topics in Medicinal Chemistry Glycogen Synthase Kinase-3 Beta; A New Target in Pancreatic Cancer?
Current Cancer Drug Targets